Short Steroid Taper Tested With Tocilizumab for GCA Short Steroid Taper Tested With Tocilizumab for GCA

Results from a pilot study examining a shortened prednisone taper of 8 weeks ' length rather than 26 weeks suggest it may be possible to reduce patients ' duration of exposure to glucocorticoids.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news